
zzso use of zzso is a risk factor for zzso and zzso zzso zzso the protective effect to develop osteoporosis in female patients with zzso with zzso zzso 

This study investigates the risk of osteoporosis associated with zzso use by comparing the zzso of osteoporosis in female cancer patients treated with and without zzso 

A zzso zzso zzso retrospective analysis was performed using the zzso Health Insurance Database 2000 and zzso for zzso Illness Patients of zzso A zzso cohort of zzso female patients without a history of osteoporosis during zzso and then zzso patients who subsequently developed osteoporosis as the osteoporosis group, were zzso zzso patients were selected from the zzso cohort without osteoporosis and frequency matched to each osteoporosis case zzso for age, year of cancer diagnosis, and index zzso zzso zzso was used to estimate the odds ratios and zzso confidence zzso and the multivariable model was applied to control for zzso 

Female cancer patients who received zzso had a zzso lower risk of developing osteoporosis than zzso users, but this risk reduction was not zzso For patients treated with zzso the zzso group had significantly lower odds in developing osteoporosis than the zzso zzso 

zzso treatment is not associated with the zzso of zzso and zzso zzso the protective effect of zzso in the development of osteoporosis in female patients with zzso in zzso 

